Pharmafile Logo
Pharmafocus logo
Advanced Search
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10

The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …

News
28246711066_52e38bc591_z

FMD would not apply in case of no-deal Brexit

February 8, 2019
Medical Communications EU, FMD, UK, brexit, falsified medicines

The Falsified Medicines Directive would be scrapped in the event of a no deal Brexit, the Association of the British …

News

J&J to include prices in drug ads on TV

February 8, 2019
Medical Communications J&J, JJ, Johnson & Johnson, Trump, pharma, pricing

US multinational Johnson & Johnson has announced that it will include the price of its medicines in TV commercials for …

News
donato_spota

Hansa Biopharma names Donato Spota as new CFO

February 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Swedish firm Hansa Biopharma has appointed Donato Spota as the company’s new Chief Financial Officer (CFO). Spota will succeed current …

Appointment
chimerix_headshots_140x140_michelle-138x138

Chimerix CEO M. Michelle Berrey to stand down as interim Office of Cheif Executive Officer is formed

February 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The North Carolina-based biopharmaceutical company Chimerex has announced that Dr M. Michelle Berrey has resigned from her role as President …

Appointment
shutterstock_360472550

Eisai and Purdue reveal positive Phase 3 data in insomnia

February 7, 2019
Research and Development Eisai, Purdue Pharma, insomnia, lemborexant, pharma

Partners Eisai and Purdue Pharma have lifted the curtain on Phase 3 clinical data on their jointly developed therapy lemborexant …

News
white-house-13863_960_720

Pharma chiefs will testify at Senate hearing on rising drug prices

February 7, 2019
Sales and Marketing CEO, J&J, JJ, Pfizer, Sanofi, Senate, pharma, pricing

The Chief Executives of Pfizer, Sanofi and Bristol-Myers Squibb have said that they will join four other pharma execs in …

News

FDA approves first therapy for acquired thrombotic thrombocytopenic purpura: Sanofi’s Cablivi

February 7, 2019
Sales and Marketing Calblivi, FDA, Sanofi, acquired thrombotic thrombocytopenic purpura, pharma

Following swiftly on the heels of the previous success with the announcement of positive Phase 3 data for Icaria in …

News

HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice

February 7, 2019
Research and Development HIV, dementia, inflamation

Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …

News

Pfizer ignores strike in Ireland as 900 employees’ pensions affected

February 7, 2019
Business Services Ireland, Labour Court, Pfizer, cork, strike

US multinational Pfizer is going ahead with its decision to transfer 900 of its Irish employees into a new defined …

News
shutterstock_273326141

NICE joins forces with Canadian peer to offer scientific advice to the pharma industry

February 6, 2019
Research and Development, Sales and Marketing CADTH, Canada, NICE, UK, pharma

NICE has announced a collaboration with its Canadian counterpart, the Canadian Agency for Drugs and Technology in Health (CADTH), with …

News

Sanofi’s Icaria combo extends progression-free survival in multiple myeloma at Phase 3

February 6, 2019
Research and Development Icaria, Sanofi, multiple myeloma, pharma

Sanofi has continued to make progress in the development of Icaria (isatuximab), with the company announcing that the therapy met …

News
genentech_web

Genentech to develop ‘highly active cytokine’ with Xancor in deal worth $300m

February 6, 2019
Research and Development Cancer, Genetech, IL-15 cytokine, Roche, Xancor, oncology

Roche’s Genentech unit has agreed to pay $120 million upfront as part of a research and licensing deal with California-based …

News
shirelabsus

Takeda ordered to pay Bayer $155.19 million over patent infringement

February 6, 2019
Research and Development Baxalta, Bayer, Nektar Therapeutics, Takeda, adynovate

A US court has ordered Takeda Pharmaceutical’s Baxalta unit to pay German firm Bayer AG $155.19 million for infringement of …

News
mr058666-web

GSK buys Merck KGaA’s cancer immunotherapy for $4.2 billion

February 6, 2019
Research and Development GSK, M7824, Merck, immunotherapy

British multinational GlaxoSmithKline has agreed to pay up to €3.7 billion ($4.2 billion) for the rights to Merck KGaA’s next …

News
harald_fricke

Czech biotech SOTIO appoints experienced immune-oncology doc as new CMO

February 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Czech biotech SOTIO has announced the appointment of Dr Harald Fricke as the firm’s Chief Medical Officer (CMO). Dr Fricke, …

Appointment
robert_friesen

Former Ablynx exec joins Kiadis as Chief Scientific Officer

February 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, appointment, kiadis, pharma

Dutch/US firm Kiadis Pharma revealed that Dr Robert Friesen became its new Chief Science Officer (CSO) as January turned into …

Appointment
lilly_building_with_american_flag_web

Lilly’s Olumiant impresses in twin Phase 3 atopic dermatitis trials

February 5, 2019
Manufacturing and Production, Research and Development Eli Lilly, Olumiant, atopic dermatitis, pharma

Eli Lilly has unveiled new Phase 3 data from two studies into the oral Janus kinase (JAK) inhibitor Olumiant (baricitinib). …

News
astrazeneca_building_white

AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug

February 5, 2019
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus

It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …

News

More than 200 Xanax-related deaths in UK since 2015

February 5, 2019
Manufacturing and Production Pfizer, UK, benzodiazepines, health, public health, xanax

There have been more than 200 deaths linked to misuse of the anti-anxiety drug Xanax in the UK since 2015. …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026